Rolfsen Consulting AB

All filings by Rolfsen Consulting AB on record concern InDex Pharmaceuticals Holding AB. The record holds 3 filings, all for trades on 5 February 2021.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 9 February 2021: a transaction, in InDex Pharmaceuticals Holding AB. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.